ELV Stock Analysis: Buy, Sell, or Hold?
ELV - Elevance Health, Inc.
$425.17
8.94 (2.15%)
▲
5d:
+4.16%
30d:
+5.09%
90d:
+36.48%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jul 15, 2026
1d
Smart Money Distribution
None View Scanner →
Strength: 7.4/10
Get Alerted When ELV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ELV shows positive signals but monitor for confirmation. Market pricing in 5.7% growth. Moderate conviction.
💡 BUY OPPORTUNITY: ELV shows positive signals but monitor for confirmation. Market pricing in 5.7% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$493.82
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$306.62
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELV is currently trading at $425.17, which is considered extended relative to its 30-day fair value range of $391.95 to $417.66. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.5) compared to its historical average (12.3). At these levels, the market is pricing in 5.7% annual earnings growth.
Technical Outlook: Technically, ELV is in a uptrend. The price is approaching resistance at $426.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ELV is in a uptrend. The price is approaching resistance at $426.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$391.95 -
$417.66
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($431.48)
- BULLISH: Expecting earnings turnaround to 5.7% growth with 2.6% revenue growth
Trading Range Analysis
30-Day Trading Range
$391.95 -
$417.66
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$386.76
Resistance Level
$426.66
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.50
Wall Street Target
$431.48
(+1.5%)
Revenue Growth (YoY)
2.6%
Earnings Growth (YoY)
-16.8%
Profit Margin
2.6%
Valuation Premium vs History
+5.7% premium
PE vs Historical
14.5 vs 12.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.7%
(market-implied from PE analysis)
1-Year Target
$449.40
(+6%)
2-Year Target
$475.02
(+12%)
3-Year Target
$502.10
(+18%)
3-Yr Target (if PE normalizes)
(PE: 15→12)
PE COMPRESSION
$425.93
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 9.0%)
$826.41
(+94%)
Base:
(SPY PE: 14.5, Growth: 9.0%)
$550.16
(+29%)
Bear:
(PE: 12.3, Growth: 9.0%)
$466.71
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 17.64 | Current EPS (TTM): $23.60
Bull Case
$568.89
(+34%)
Analyst growth 24.3%, PE expands to 19.4
Base Case
$517.17
(+22%)
Market implied 24.3%, PE stable at 17.6
Bear Case
$283.04
(-33%)
Severe decline -20.0%, PE contracts to 15.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 6:34 PM ET
Data refreshes hourly during market hours. Next update: 7:34 PM
Data refreshes hourly during market hours. Next update: 7:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELV showing a specific setup today?
Insider Activity (6 Months)
2
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Amy W Schulman
SELL
26 shares
2026-03-12
Ro Khanna
BUY
2026-02-24
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$109 | 65 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$420 | 54 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 62 BUY |
|
HUM
Humana Inc |
HOLD
26 analysts |
$315 | 58 HOLD |
|
CNC
Centene Corp |
BUY
19 analysts |
$63 | 56 HOLD |
Advanced ELV Option Strategies
Professional options setups generated by AI based on today's ELV price and gamma walls.
